*****This thread is setup mainly to gain information
relating to Mediwatch in a quick and easy way and IS IN NO WAY A
RECOMMENDATION TO BUY!********


Mediwatch-A Synopsis:
Mediwatch was established in 1996 and has developed a range of specialist
medical equipment for the diagnosis of urological disorders.The group joined the
AIM in 2000 through a reverse into Prostcare plc,which at the time was valued at
8m.While the vast majority of sales were generated in the UK,there was a
substantial indirect export business involving a number of agents,supplying into
Europe,North America,Australasia and Asia,notably Japan.
Group revenues are set to increase rapidly following the acquisition of the former
Medtronic Urodynamis Division,which has introduced a fundamental presence in
North America.The deal was in 2006 with the sales division building from 2007.
With the inclusion of the Medtronic systems now owned by Mediwatch they now
can offer a 'One Stop Shop' for the diagnosis of various urology disorders with the
benefit of Mediwatch systems having the ability to electronically send data from the
various tests to a central data base!Oh and plus the added bonus of PSAwatch and
now PCA3plus!

More than 30 million PSA tests are performed annually in the USA alone!

CHARTS

FUTURE EVENTS AND LATEST
NEWS

Just for the record and to even things up,this is Treblewide's view (near end
of 2008):

"in short 3p by chrimbo and a real chance if they do not get rid of management they
will go into receivership.....when they bough the MDT business I said at the time it
must have been a bag of shite as they only paid buttons for it.......looks like that was
fairly correct......i feel sorry for shareholders"

Treblewide has been filtered from my eyes for his abuse,lies and general behavior but
it's a free country (I think) so do as you see fit.


It started with:

Treblewide - 05 Jun 2007 15:49 - 33 of 1747
still short

Treblewide - 18 Jun 2007 00:24 - 69 of 1747
interesting stuff from that article...very few men die from prosate cancer and it is not an agressive disease....treatment can be worse than the disease.......kind of suggests their whole business model is based on sand to me.......but hey who wants a balanced view.

Treblewide - 18 Jun 2007 00:31 - 76 of 1754
exercise and sex may cause a raised PSA...so you guys may have stumbled on a test for fit shaggers :-)

I am gonna name Me-Di-Watch

Gonna-go-bust-soon-iwatch

Treblewide - 18 Jun 2007 10:59 - 85 of 1754
minder...i do not make light of prosate cancer....show me one post where I do...i make fun out of this company yes but not the disease so wind yer neck in pal.

show me any trace of a profit and i will maybe change my mind

Treblewide - 18 Jun 2007 15:54 - 97 of 1754
minder made a small loss yes which I have more than made up for shorting it........and i guess your average holding is 3p.....aye right.

Aalso I closed out my short at 8p for a loss of the spread if memory serves me correctly.

currently short from 13.25....i thank you and goodnight

Treblewide - 23 Jul 2007 12:36 - 154 of 1747
more of the same......thank god i still do not own shares in this lot...will they ever
make a penny profit....looks doubtful......cannot even manage a small supply chain.


ect ect ect

with the last few posts:

Treblewide - 30 Mar 2009 09:16 - 1704 of 1754
you are a lunatic mick.....words fail me.

and ps i only post under treblewide on any financial web site....i know you cannot say the same......you have been calling this as a buy and nothing but a buy for about 7 years...it says it all really about your stock picking ability

i notice the downtrend ins now establishing itself....re-visit of the lows again by the looks of things

Treblewide - 30 Mar 2009 22:41 - 1712 of 1754
mick no i dont know what each product does...i dont think that is important...the numbers tell everything and even though you must spend hours on web sites searching for stuff that is not even related to MDW you fail to grasp the basics...they consistently lost money and now seem to be making some...my call to 3p was correct and i think if they had not got their shit together they could have gone under

i was not interested in them as a long play while they were loosing money depsite whatever rubbish you posted regarding piss sticks or whatever you bang on about.

and yes it was poor trading..having an avergae of 12 and averaging down to 6-7p while they were at 3p....is terrible trading...that cannot even be debated...the very fact you know so much about the products means you have fallen in love with this company......which is very dangerous when investing....

the numbers are the important things...i was right on 3p, the company is posting slightly better figures but we are in a bear market which has not bottomed yet so the price will fall further

you are a 1 trick pony that posts irrelevant links...dont bother to respond i can be bothered getting into a debate with you.....away and cut and paste some more flags

toodlepip

**************************************************************

I have been chased from here and now ADVFN,has the boy got a problem?

treblewide - 3 Aug'09 - 14:46 - 22345 of 22412


post 22342 is classic.....so mick advfn is not a good source when the consensus is sell?

begs the question why you spend so much time polluting it with your bull tripe?

question....so MDW share price has gone up, it has gone down etc etc...during all of that time has mick ever been able to find any subjectivity in his posting ie has he ever critisised anything?

i really think he may be getting paid by MDW...the whole thing is very bizzare.

mick i notice you referred to your threads as "promotion of Mediwatch"

can you confirm if you are getting financially rewarded by the company for this?

treblewide - 3 Aug'09 - 23:55 - 22371 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....



treblewide - 4 Aug'09 - 00:19 - 22373 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....

treblewide - 4 Aug'09 - 10:49 - 22379 of 22412


still time to get out at 6p.....dont understand why you would not sell at 6p when they are obviously going to half in value...if you are a long term mdw bull you can buy twice as many shares at 3p and maybe possibly one day see a profit on your holding?



treblewide - 4 Aug'09 - 12:44 - 22381 of 22412


last chance to sell at 6p for your shares folks


treblewide - 4 Aug'09 - 14:48 - 22387 of 22412


so question...is psawatch is so great...why has there been no huge surge in revenue figures from UK and Europe on the back of it being sold?

the whole reason a lot of you hold this is psawatch...it has not made them any money in Europe which could be argued when taken as a whole is not much smaller than the USA.....this company is not going to change overnight with US approval...at bets it would be a selling opportunity for long term holders

i really think a lot of you have to ignore some of the nonsense ramping going on here...the company is draining cash and there margins are reducing (despite this wonder PSA machine they have for sale)

i really think the future looks bleak for mediwatch...if someone can put in concise terminology why MDW is a buy i am all ears....dont point me at fairfax report...they are a bunch of clowns as well...that interim report is shocking and i mean really poor.

costs out of control...margins squeezed, cash running out...no real revenue growth, does this sound like a growth company to you?

sell at 6p


treblewide - 4 Aug'09 - 15:50 - 22391 of 22412


god i have heard it all now...mick can you counter my points about declining margins and cash issues without nonsense posts about peopel having insider information...what a crock and what a clown.

so just so i have this straight in my head...when you put in effort to ramp these shares it is all great and you expect cuddles? (and if anyone disagrees you throw your toys out the pram liek an old woman)

when i put up a few posts to explain why i am short it is an organised attempt to get the share price down because i have insider inforamtion from the US?

were you the Iraqi information minister in a previous role? lol


treblewide - 5 Aug'09 - 19:24 - 22409 of 22412


lol.....shares getting sold today at 5.75.....next stop 3p...

treblewide - 4 Aug'09 - 12:44 - 22381 of 22408 edit


last chance to sell at 6p for your shares folks




treblewide - 5 Aug'09 - 19:29 - 22410 of 22412


i wonder what thier overdraft is limited to....1M?

if so they have 12 months of life left at current perfomance...how many of you hlders have considered the chances of them going bust?....i would not rule it out...would love to know how much further the banks will let them go into debt before they pull the plug

treblewide - 5 Aug'09 - 19:37 - 22411 of 22412


seriously if i were a holder i would look at the interims and ask how much longer can they go on burning cash.......and with all the averaging down the bulls have done over the years i bet some are more exposed than they should be....good luck...think you might need it




ANYWAY

http://mediwatch.blogspot.com/

There you go Banjo....your news:



Mediwatch PLC
22 November 2007

Issued by Citigate Dewe Rogerson Ltd, Birmingham
Date: Thursday, 22 November 2007
Embargoed: 7.00am


Mediwatch Plc
Strategic Relationship Established with US Long Term Care Partner


Mediwatch Plc ('Mediwatch') (AIM: MDW) the innovative medical equipment
manufacturer has signed a substantial contract to supply a comprehensive range
of diagnostic urological products to US company, specialising in Geriatric
Rehabilitation, Accelerated Care Plus Corp. ('ACP').

The three year sales and original equipment manufacturer ('OEM') deal should be
worth at least 2 million over the life of the agreement.

It enables Mediwatch's diagnostic urological equipment to enter America's
medical equipment market catering for its rapidly growing requirement for
long-term care of the elderly.

Accurate, reliable and easy-to-use urological diagnostics are essential to
manage urinary incontinence, one of the primary reasons patients are
institutionalised.

ACP already services over 3000 Skilled Nursing Facilities ('SNFs') that provide
skilled nursing and rehabilitation services to sub-acute, chronic and
outpatients and continues to pursue an aggressive growth strategy.

Said Mediwatch CEO Philip Stimpson: 'Mediwatch equipment is increasingly being
recognised around the globe as the Gold Standard in urological diagnostics.'

'We've used innovation and design to create portable equipment which can quickly
carry out tests once confined to large, expensive, high-tech clinical
environments.

'We believe this approach is the way ahead, cutting costs, saving time and
enabling clinicians and patients to get swift results where they need them, when
they need them.'

The range of diagnostic equipment supplied by Mediwatch to ACP for the US market
will include a customised version of the Portascan which will include
cystometry, ultrasonic imaging and uroflow along with additional Mediwatch
products as developed.

ACP's Chief Technology Officer Dr. Chris Castel welcomed the opportunity to work
cooperatively with Mediwatch.

He said: 'Urinary Incontinence is a significant cause of suffering in the
elderly population. We have chosen Mediwatch's equipment for its excellent
design, portability and ease of use by our clinicians. As a company, we have
taken a strategic decision to partner with Mediwatch in the long term care
market as they have a track record for innovation and product quality, and will
develop unique products in conjunction with ACP, targeted towards the diagnosis
and management of incontinence in the elderly.'

Enquires:
Mediwatch plc Citigate Dewe Rogerson
Philip Stimpson, Chief Executive Fiona Tooley, Director
Colin Kunz, Finance Director Keith Gabriel, Senior Account Manager
Tel: +44 (0) 1788 547888 Tel: +44 (0) 121 455 8370

Morning Opto,
Cheers for posting and excellent news.Hopefully this is just the start of a stream of announcements.

From todays long awaited announcement here is the link to the ACP website:

http://www.acplus.com/healthcare.html

and along with some figures found there within:

"Incontinence Management is an especially challenging market. Incontinence alone affects over 13 million Americans - 10 to 30% of adults and 50% of nursing home residents. It is a $16 billion market. Nearly half of the 2.3 million congregate care residents are incontinent. While normal aging is not a cause of bladder control problems, age-related medical and surgical conditions can increase the risk for loss of bladder control. The truth is uncontrolled leakage of urine is common but is also highly treatable and often curable!"


"Although the incidence of incontinence is already significant, it is expected to grow dramatically as the U.S. population continues to age. According to the U.S. Administration on Aging, there are currently 74 million men and women in the United States who are over 50 years old. The Administration estimates that this number will grow by nearly 50% to over 110 million by 2020. Similarly, the over 65 population is projected to nearly double in the next 10 years to 39.4 million. In this segment, 50% or more of the population has some incidence of incontinence, with even higher concentrations among women."

The reason and this is just my opinion that we dropped was due to the extra little (well big) part that MDW issued as a foot note issued in the Interims dated 23rd July 2007:

Sales growth has been strong but was initially delayed as a result of several
factors, including:

read the rest via the link below.

http://moneyam.uk-wire.com/cgi-bin/articles/200707231105336775A.html

MDW are back on track now so I would expect a return to at least 12p very soon!


In my opinion dyor,ect ect ect

Now come on Banjo. Let's think about much more than 12p here soon :-)

lol Opto,
12p was my conservative estimate and I was going to say 14p but may struggle unless further news is released soon!

12p on the other hand is easily achievable within the next week or so-imo.

MDW are renowned for keeping quiet but get there in their own time and at their own pace BUT get it right first time when they deliver! I have followed them closely for years so I can say that hand on heart.

I'm the first to admit that the last six months have been a nightmare and I was very close to selling up! Not now though,the RNS was very well worded and if MDW's past performance is anything to go by this long wait was justified by them,for whatever reason,and news flow will now increase in my opinion.

What yesterdays announcement does show is that MDW are not just about PSAwatch!!!!!!!!!!!!!!!!!! I for one get hooked on the blighter and although still very important it's by no means the main concept here but obviously has the ability to be a big revenue generator!

We would have seen 12p today with a little more volume,maybe Monday :-)

A Trading Statement (if positive) would get things going but if not forthcoming then further announcements on contracts would suffice.

Just having a quick look around-

From the Interims in July:

"more than 60 new distributorships set-up worldwide to promote
Mediwatch products; the benefit of which will be reflected in the second half."

I don't think we have had this one before-

Hungary

"Since its fundation Omikron Ltd. has been distributing medical devices for non-invasive functional diagnostic examinations. Complete urology, gastroenterology, andrology, pulmonology and sleep apnea labs can be equiped with the distributed systems."

http://www.omikron-ltd.hu/


Mediwatch Products found under 'Urolia',surprisingly enough :-)

Specialist Service Engineer


-- Posted on Tuesday, October 9 2007

Due to continued expansion Mediwatch plc is seeking to recruit an additional service engineer to cover its range of Urology products.

Mediwatch plc is one of the worlds leading suppliers of urodynamic, and urology biochemistry and ultrasound systems. We are continuing to expand our range of systems and install base and we now have an opportunity for a field service engineer who will be able to provide support both to the office based service department, and the field service in the north of the UK.

You will also be required to provide support to the international support and training team, and therefore some foreign travel will be required. You will have a variety of responsibilities, and after training, you will be able to install, service systems and train end users, Mediwatch agents and biomedical engineers on the systems.

http://www.ebme.co.uk/cgi-bin/news/viewnews.cgi?id=EEAEAkpEuuByFJkeeD&style=news&tmpl=rec_page

MDW have already set there stall out for the AUA 2008:

Another distributor,AVF Perimedical?

France,with at least four MDW products showing:


http://www.avf-perimedical.com/matrielurologie-c-28_160.html?osCsid=8ad

Good afternoon Banjo, I don't know how you find it all!
It's been a dull boring time with MDW but now looks like things are going to hot up.
Results early Jan I believe so could become active very soon.....keep digging :-)

Afternoon Opto,It's called using a search engine..........I believe. :-)

If the Final Results are due in January then yes volume should pick up and when combined with the latest USA announcement (with more to follow-imo) we may even see a whooosh!

Re ACP announcement-'additional Mediwatch products as developed.'

and 'As a company, we have taken a strategic decision to partner with Mediwatch in the long term care market as they have a track record for innovation and product quality, and will develop unique products in conjunction with ACP':




"The range of diagnostic equipment supplied by Mediwatch to ACP for the US market
will include a customised version of the Portascan which will include
cystometry, ultrasonic imaging and uroflow along with additional Mediwatch
products as developed.

ACP's Chief Technology Officer Dr. Chris Castel welcomed the opportunity to work
cooperatively with Mediwatch.

He said: 'Urinary Incontinence is a significant cause of suffering in the
elderly population. We have chosen Mediwatch's equipment for its excellent
design, portability and ease of use by our clinicians. As a company, we have
taken a strategic decision to partner with Mediwatch in the long term care
market as they have a track record for innovation and product quality, and will
develop unique products in conjunction with ACP, targeted towards the diagnosis
and management of incontinence in the elderly.'"

In my opinion we should class the recent USA deal as a pivotal turning point, not for MDW as that occurred earlier this year but for share holders both present and future.

As said before the MDT deal was massive and a major undertaking for any company to restructure,reinvent,increase distribution map and intwine both companies products into a one product band,sorry brand (been playing me banja)

So,with that said here is what MDW do and an explanation of the main fields they cover:

"Mediwatch has developed a range of medical equipment for the diagnosis of a variety of clinical conditions. Mediwatch focuses it's design skills on unique diagnostic products that can be used with simplicity, across the medical profession, by healthcare providers with different levels of clinical expertise.

Mediwatch's research and development strategy draws on extensive clinical knowledge with a seamless interface between the point-of-care and innovation with cutting-edge technology."

Urology

Urology is the study and treatment of diseases of the urogenital tract. Awareness of urological disorders and patient-specific disease management is increasing with on-going advances in the quality and specificity of diagnostic testing.

Diagnostic Ultrasound

Diagnostic ultrasound is the use of ultrasonic or high-frequency sound waves to produce images of the internal organs of the body specifically for diagnostic purposes. Diagnostic ultrasound is a painless, non-invasive imaging technique.

Urodynamics

Urodynamics is the investigation of the function and dysfunction of the lower urinary tract. Urodynamic studies involve the measurement of pressure, flow or electrical activity of the lower urinary tract.

Point-of-care Biochemistry

Point-of-care clinical tests utilise blood, body fluids or secretions in biochemical reactions to diagnose or monitor a variety of medical conditions.

Website updated with the new ACP deal,not earth shattering news but news all the same! :-)

and another one..........


Mediwatch plc
('Mediwatch' or 'the Company')
Strategic Relationship Established Between
Mediwatch and Device Technologies


To address the rapidly growing requirement for long-term care of the elderly in
Australia and New Zealand, Mediwatch Plc ('Mediwatch') (AIM: MDW), the
innovative medical equipment manufacturer, has signed a contract to supply a
comprehensive range of diagnostic urological products to leading Australian
medical devices company Device Technologies Pty. Ltd. ('Device Technologies').

The range of diagnostic equipment supplied by Mediwatch to Device Technologies
for the Australian and New Zealand market will include: Portascan+(TM),
Multiscan(TM), Portaflow(TM), Urodyn 1000(TM), Duet LogicTM, Duet Encompass(TM),
Sensic G3(TM)

The five year sales deal is estimated to be worth in the region of 3 million
over the contract period. The deal follows the recent announcement (Thursday 22
November 2007) of a two year sales contract with Accelerated Care Plus Corp with
an estimated worth of at least 2 million.

Morning petralva,
All looking rather good :-)

all we need now is fda approval for psa...............and off we go.

Device Technologies is an independent, privately-owned Australian company. Established in 1992, it employs 250 people in Australia and New Zealand and operates sales offices in every Australian state and in Auckland, New Zealand.


"It markets and sells high quality capital equipment and medical device consumables. Products are imported from the USA and Europe as well as being locally manufactured.

Our independent status enables us to be selective in the products we distribute, the services we provide and the people we employ."



"Company Mission Statement

To supply cost effective and technologically innovative products to Australian healthcare clients using professionally superior sales distribution and service facilities.

Device Technologies is committed to quality. Quality of product and service is our goal. We aim to achieve this through our quality management system (AS/NZS ISO 9001), as well as our marketing, sales, customer service, purchasing, warehousing, regulatory and distribution divisions.

We provide the medical and surgical staff of the Public and Private Healthcare Institutions with advanced education and superior technical support and customer service, as well as the latest clinical research data internationally available."


Device Technologies